What is a cohort study design and when is it most appropriate in infectious disease epidemiology?

• A. Follows a defined group over time to observe disease outcomes; appropriate when exposure status is known and can be measured at baseline; good for vaccine effectiveness.
• B. Randomizes participants to exposure groups.
• C. Cross-sectional survey at a single time.
• D. Case series of hospitalized patients.

Answer: (D)

A cohort study follows a defined group over time, starting by determining each person’s exposure status at baseline and then watching to see who develops the disease. This setup lets you measure incidence and compare how often disease occurs in those exposed versus unexposed, giving a clear sense of temporality between exposure and outcome. In infectious disease epidemiology, this design is especially useful for evaluating how a particular exposure—such as vaccination, contact with an infected person, or a specific risk factor—affects subsequent risk of infection or disease. It’s particularly well suited for estimating vaccine effectiveness, because you can directly compare infection rates in the vaccinated and unvaccinated within the same cohort and derive a risk ratio or related measure of protection.

Other designs described in the options don’t provide the same advantages. Randomizing participants to exposure groups is an experimental approach, not a cohort design. A cross-sectional survey captures exposure and disease at a single point in time, so it cannot establish temporality or incidence. A case series describes a group of patients with the disease without a comparison group, offering no information about risk or exposure effects.